Showing results (1-10 of 131) with videos related to
Sort By:
Pageof 14
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|June 7, 2019
[Mature T- and NK-cell lymphomas]Makoto YoshimitsuLeukemia Research|January 19, 2025
Targeted antibody therapy as a treatment strategy for aggressive adult T-cell leukemia/lymphomaMakoto Yoshimitsu[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|July 5, 2023
[Adult T-cell leukemia/lymphoma: progress in understanding of pathogenesis and treatment]Makoto Yoshimitsu[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|October 29, 2023
[Adult T-cell leukemia/lymphoma]Makoto YoshimitsuRecent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|September 7, 2013
Prevention of human T-cell lymphotropic virus type 1 infection and adult T-cell leukemia/lymphomaMakoto Yoshimitsu, Yohann White, Naomichi ArimaMolecular Therapy : the Journal of the American Society of Gene Therapy|March 28, 2007
Anti-CD25 targeted killing of bicistronically transduced cells: a novel safety mechanism against retroviral genotoxicityShobha Ramsubir, Makoto Yoshimitsu, Jeffrey A MedinBiochemical and Biophysical Research Communications|October 4, 2014
CD160 expression defines a uniquely exhausted subset of T lymphocytes in HTLV-1 infectionChioma Ezinne Chibueze, Makoto Yoshimitsu, Naomichi ArimaVirology|October 16, 2015
I-mfa domain proteins specifically interact with HTLV-1 Tax and repress its transactivating functionsShuichi Kusano, Makoto Yoshimitsu, Miho Hachiman, et al.Plos One|February 8, 2014
HTLV-1 specific CD8+ T cell function augmented by blockade of 2B4/CD48 interaction in HTLV-1 infectionChibueze Chioma Ezinne, Makoto Yoshimitsu, Yohann White, et al.International Journal of Nanomedicine|October 3, 2012
Liposomes and nanotechnology in drug development: focus on oncotargetsTomohiro Kozako, Naomichi Arima, Makoto Yoshimitsu, et al.Pageof 14